Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Lenting

Showing results (41-50 of 170) with videos related to

Pageof 17
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
On the versatility of von Willebrand factorAntoine Rauch, Nikolett Wohner, Olivier D Christophe, et al.
Haematologica|August 21, 2020
Monoclonal gammopathy of clinical significance: <i>in vivo</i> demonstration of the anti-thrombotic effect of an acquired anti-thrombin antibodyBerenice Schell, Celine Desconclois, Xavier Mariette, et al.
Journal of Translational Medicine|January 22, 2026
Magnetostaltic pumping in an ex vivo extracorporeal membrane oxygenation modelMohammadreza Zolala, Veronique Heim, Cécile V Denis, et al.
Blood|February 9, 2011
The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasmaJunmei Chen, William E Hobbs, Jennie Le, et al.
The Journal of Biological Chemistry|April 2, 2002
The connecting segment between both epidermal growth factor-like domains in blood coagulation factor IX contributes to stimulation by factor VIIIa and its isolated A2 domainPatrick H N Celie, Gunny Van Stempvoort, Caroline Fribourg, et al.
Blood|July 15, 2005
A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2BJanine J J Hulstein, Philip G de Groot, Karen Silence, et al.
The Journal of Biological Chemistry|January 11, 2003
Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIIINiels Bovenschen, Ria C Boertjes, Gunny van Stempvoort, et al.
Journal of Thrombosis and Haemostasis : JTH|August 20, 2019
A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factorStephen Ferrière, Charlotte Kawecki, Jean-François Ottavi, et al.
Haematologica|June 27, 2012
Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5Julie N Pegon, Mohamad Kurdi, Caterina Casari, et al.
Journal of Thrombosis and Haemostasis : JTH|November 24, 2021
Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cellsNikolett Wohner, Silvie Sebastian, Vincent Muczynski, et al.
Pageof 17

Showing results (41-50 of 170) with videos related to

Sort By:
Pageof 17
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
On the versatility of von Willebrand factorAntoine Rauch, Nikolett Wohner, Olivier D Christophe, et al.
Haematologica|August 21, 2020
Monoclonal gammopathy of clinical significance: <i>in vivo</i> demonstration of the anti-thrombotic effect of an acquired anti-thrombin antibodyBerenice Schell, Celine Desconclois, Xavier Mariette, et al.
Journal of Translational Medicine|January 22, 2026
Magnetostaltic pumping in an ex vivo extracorporeal membrane oxygenation modelMohammadreza Zolala, Veronique Heim, Cécile V Denis, et al.
Blood|February 9, 2011
The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasmaJunmei Chen, William E Hobbs, Jennie Le, et al.
The Journal of Biological Chemistry|April 2, 2002
The connecting segment between both epidermal growth factor-like domains in blood coagulation factor IX contributes to stimulation by factor VIIIa and its isolated A2 domainPatrick H N Celie, Gunny Van Stempvoort, Caroline Fribourg, et al.
Blood|July 15, 2005
A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2BJanine J J Hulstein, Philip G de Groot, Karen Silence, et al.
The Journal of Biological Chemistry|January 11, 2003
Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIIINiels Bovenschen, Ria C Boertjes, Gunny van Stempvoort, et al.
Journal of Thrombosis and Haemostasis : JTH|August 20, 2019
A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factorStephen Ferrière, Charlotte Kawecki, Jean-François Ottavi, et al.
Haematologica|June 27, 2012
Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5Julie N Pegon, Mohamad Kurdi, Caterina Casari, et al.
Journal of Thrombosis and Haemostasis : JTH|November 24, 2021
Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cellsNikolett Wohner, Silvie Sebastian, Vincent Muczynski, et al.
Pageof 17